33 results
Page 2 of 2
8-K
EX-99.2
m6imhcobzp55szx91pk1
31 Jul 23
Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer
4:30pm
8-K
EX-99.1
jc4nv nzxv
3 Nov 22
Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023
6:45am
8-K
EX-99.1
o8ua3dbe
16 Aug 21
Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update
4:11pm
424B4
3phi y8dzyove
24 Jul 20
Prospectus supplement with pricing info
5:15pm
S-1/A
s99 kyb6to
20 Jul 20
IPO registration (amended)
6:07am
S-1
2jgblbe6
2 Jul 20
IPO registration
12:00am
DRS/A
zuuxuktat7nj7st72
26 Feb 20
Draft registration statement (amended)
12:00am
DRS/A
njf2jay4f8
6 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
y4adca66hsr5kz786y0i
8 Nov 19
Draft registration statement (amended)
12:00am
DRS
pba0 jxim
18 Sep 19
Draft registration statement
12:00am